Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stride (LRN) Shares Outstanding (Diluted Average) (2017 - 2023)

Stride (LRN) has disclosed Shares Outstanding (Diluted Average) for 11 consecutive years, with $43.5 million as the latest value for Q4 2023.

  • Quarterly Shares Outstanding (Diluted Average) rose 2.02% to $43.5 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $43.5 million through Dec 2023, up 2.02% year-over-year, with the annual reading at $42.7 million for FY2023, 0.68% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2023 was $43.5 million at Stride, up from $43.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $43.5 million in Q4 2023, with the low at $39.3 million in Q3 2019.
  • Average Shares Outstanding (Diluted Average) over 5 years is $41.7 million, with a median of $42.1 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) grew 7.38% in 2020, then fell 3.86% in 2021.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $40.7 million in 2019, then grew by 2.43% to $41.7 million in 2020, then rose by 1.76% to $42.4 million in 2021, then rose by 0.44% to $42.6 million in 2022, then increased by 2.02% to $43.5 million in 2023.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $43.5 million, $43.0 million, and $42.7 million for Q4 2023, Q3 2023, and Q2 2023 respectively.